And so pharma profiteers again
World of DTC Marketing
APRIL 14, 2021
Best of all are patients in the US, where prices are highest, and with chronic conditions requiring repeat prescriptions. The argument is that this is the only way to cover research and development (R&D) cost for new drugs. Drug companies on average spend about 20% of all their sales revenue on R&D.
Let's personalize your content